Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 9 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spyre Therapeutics, Inc. | 550,540 | reported | 16 Mar 2022 | tx 65+3,160,982−522,590 |
| Kaleido Biosciences, Inc. | 15,000 | reported | 30 Jun 2021 | tx 4+42,853−25,707 |
| Generation Bio Co. | 0 | reported | 09 Feb 2026 | tx 21+603,699−183,822 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Feb 2026 | TENDER | Generation Bio Co. | 29,928 | — | |
| 09 Feb 2026 | TENDER | Generation Bio Co. | 7,283 | — | |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 2,500 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 1,920 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 1,500 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 5,200 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 3,000 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 6,000 | — | deriv |
| 04 Jun 2025 | GRANT_AWARD | Generation Bio Co. | 30,000 | 0.00 USD | deriv |
| 10 Jan 2025 | PURCHASE | Generation Bio Co. | 125,791 | 0.96 USD | first after silence |
| 13 Jan 2025 | PURCHASE | Generation Bio Co. | 85,000 | 0.97 USD | |
| 06 Jun 2024 | GRANT_AWARD | Generation Bio Co. | 60,000 | 0.00 USD | deriv |
| 01 Dec 2023 | PURCHASE | Generation Bio Co. | 88,495 | 1.41 USD | first after silence |
| 08 Jun 2023 | GRANT_AWARD | Generation Bio Co. | 25,000 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | Generation Bio Co. | 19,200 | 0.00 USD | deriv |
| 16 Mar 2022 | PURCHASE | Spyre Therapeutics, Inc. | 80,079 | 2.34 USD | |
| 11 Mar 2022 | PURCHASE | Spyre Therapeutics, Inc. | 34,777 | 2.06 USD | |
| 14 Mar 2022 | PURCHASE | Spyre Therapeutics, Inc. | 67,472 | 1.93 USD | |
| 15 Mar 2022 | PURCHASE | Spyre Therapeutics, Inc. | 42,417 | 1.86 USD | |
| 17 Feb 2022 | GRANT_AWARD | Spyre Therapeutics, Inc. | 350,000 | 0.00 USD | deriv |
| 18 Oct 2021 | GIFT | Spyre Therapeutics, Inc. | 23,809 | 0.00 USD | |
| 20 Oct 2021 | GIFT | Spyre Therapeutics, Inc. | 10,000 | 0.00 USD | |
| 20 Oct 2021 | GIFT | Spyre Therapeutics, Inc. | 10,000 | 0.00 USD | |
| 18 Oct 2021 | GIFT | Spyre Therapeutics, Inc. | 23,809 | 0.00 USD | |
| 28 Dec 2018 | GIFT | Spyre Therapeutics, Inc. | 57,450 | 0.00 USD |
3 purchases reported after at least 12 months of silence — most recent on 10 Jan 2025.